Integra Lifesciences Holdings (IART) Debt Ratio (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Debt Ratio data on file, last reported at 0.21 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 26.67% year-over-year to 0.21; the trailing twelve-month figure through Mar 2026 stood at 0.21 (down 26.67% YoY), and the FY2025 full-year result was 0.49, up 19.32% from the prior year.
• Debt Ratio slipped to 0.21 in Q1 2026, from 0.49 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.49 in Q4 2025 to a low of 0.19 in Q2 2024.
• A 5-year average of 0.27 and a median of 0.23 in 2023 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 85.22% in 2024 and plunged 49.31% in 2025, its largest moves.
• Tracing IART's Debt Ratio over 5 years: stood at 0.22 in 2022, then climbed by 3.13% to 0.22 in 2023, then surged by 85.22% to 0.41 in 2024, then advanced by 19.32% to 0.49 in 2025, then tumbled by 56.98% to 0.21 in 2026.
• Business Quant data shows IART's Debt Ratio at 0.21 in Q1 2026, 0.49 in Q4 2025, and 0.21 in Q3 2025.